Categories: NewsNutrition

Pivot Bio’s N-OVATOR® Program Named to TIME’s list of the Best Inventions of 2024

The latest in a series of recognitions for the company

BERKELEY, Calif., Oct. 30, 2024 /PRNewswire/ — Pivot Bio, a leading sustainable agriculture company, was honored today on TIME magazine’s 2024 list of the Best Inventions, which features 200 extraordinary innovations changing our lives. The list recognized Pivot Bio’s N-OVATOR® program for pioneering a new way to financially reward farmers for the environmental benefits they deliver.

To compile this year’s list, TIME solicited nominations from TIME editors and correspondents around the world, and through an online application process, paying special attention to growing fields—such as health care, AI, and green energy. TIME then evaluated each contender on several factors, including originality, efficacy, ambition, and impact.

“We thank TIME, its editors, and contributors who picked Pivot Bio for this incredible honor. It is, first and foremost, a recognition of the incredible impact our farmers are making as they lead agriculture forward,” said Chris Abbott, Pivot Bio’s chief executive officer. “We also want to thank our corporate partners, across the food and beverage, consumer packaged goods and fuel industries, for making this innovative program possible.”

By the end of the year, Pivot Bio’s N-OVATOR program will have paid over $13 million to farmers, since its launch in 2022, for using our next generation technology to elevate nitrogen performance, and ultimately, yield. The N-OVATOR program provides annual payments to farmers based on their replacement of synthetic nitrogen with Pivot Bio’s microbial source of nitrogen, with some participants receiving payments that lower their fertilizer costs by 50%.

“We have made a commitment to our customers to deliver the highest performing, lowest cost and most sustainable source of nitrogen,” said Abbott. “Our partnerships pay farmers a premium on their commodities for the environmental benefits they deliver through the use of our microbial source of nitrogen, further reducing the cost of nitrogen fertilizer.”

Looking ahead, Pivot Bio aims to expand the N-OVATOR program by exploring opportunities in new geographies and crops and additional value chain partnerships. The company is also developing next-generation products that could replace even higher amounts of synthetic nitrogen, potentially increasing the benefits for both farmers and the environment.

This award comes on the heels of several high-profile recognitions for the company, including MIT Tech Review’s 2024 list of the 15 climate tech companies to watch, a 2024 S2G/THRIVE top 50 Ag Tech company, and Congruent Ventures and Silicon Valley Bank’s 50 by 2050 list of pioneers in carbon reduction.

See the full TIME list here: time.com/best-inventions-2024

About Pivot Bio
Pivot Bio is a leading sustainable agriculture company delivering to farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Currently available in North America, and soon in Brazil, the company’s products are a breakthrough innovation. They are among the industry’s most promising climate solutions. The company’s nitrogen is weatherproof, safer to handle, and does not leach or contribute to nitrous oxide emissions. Pivot Bio has been recognized three times by Time magazine on its annual list of best inventions, by Fast Company on its World Changing Ideas and World’s 50 Most Innovative Companies lists, by CNBC on its Disruptor 50 list of private companies, by Fortune on its Impact 20 list of startups driving social good and by MIT Tech Review as one of 15 climate tech companies to watch. For more information, visit PivotBio.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pivot-bios-n-ovator-program-named-to-times-list-of-the-best-inventions-of-2024-302291743.html

SOURCE Pivot Bio, Inc

Staff

Recent Posts

Nihon Kohden Introduces First-Ever ATO-Certified Ventilators

IRVINE, Calif.--(BUSINESS WIRE)--#RespiratoryCare--Nihon Kohden, a global leader in medical technology, today announced the introduction of…

8 hours ago

2025 Medicare Physician Fee Schedule Final Rule Includes Two Major Wins for Therapy Providers

APTA advocacy leads to impactful policy wins that will reduce administrative burden, improve access, and…

8 hours ago

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWTON, Mass., Nov. 1, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical…

8 hours ago

Gestalt and Paige Partner to Enhance Digital Pathology Workflows with Integration of Advanced AI Algorithms

SPOKANE, Wash. and NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Gestalt, a leader in digital pathology…

8 hours ago

Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use

SALT LAKE CITY and OXFORD, United Kingdom, Nov. 1, 2024 /PRNewswire/ -- Wasatch Biolabs (WBL),…

8 hours ago

The 2024 Presidential Election: What Could It Mean for Your Financial Plan?

With the upcoming election, individuals must brace for potential economic shifts and policy changes that…

8 hours ago